No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
557 |
4. Check minimum number of eventsNone |
557 |
5. Include endpointsNone |
557 |
6. Filter based on genotype QC (FinnGen only) |
557 |
Control definitions (FinnGen only)
- Control exclude
- G6_HYDROCEPH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G91
- Name in latin
- Hydrocephalia obstructiva
Similar endpoints
↥List of similar endpoints to
Obstructive hydrocephalus
based on the number of shared cases.
Similar with more cases:
- Hydrocephalus
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5759 | 2782 | 2921 |
| Only index persons | 4149 | 2069 | 2080 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.08 |
| Only index persons | 0.08 | 0.08 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 50.19 | 53.09 | 47.07 |
| Only index persons | 46.90 | 51.02 | 42.81 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 557 | 288 | 269 |
| Unadjusted period prevalence (%) | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | 55.11 | 52.12 | 58.31 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 516
- Matched controls
- 5161
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
323.0
481
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4790.4
265.4
233
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
168.1
152
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
167.0
151
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
164.6
149
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
143.6
131
*
AAF00
NOMESCO Finland
Ventriculostomy
530.0
129.0
123
*
AA1AD
NOMESCO Finland
CT of head and brain
8.4
103.1
301
735
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
14.5
99.8
182
186
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
900.0
80.7
77
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
432.9
76.9
75
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
831.8
75.2
72
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
392.5
70.4
69
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.4
64.0
144
203
AA1AA
NOMESCO Finland
Head X-ray examination
81.9
64.0
71
10
ZXD05
NOMESCO Finland
Urgent procedure
4.7
57.6
281
1046
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
57.4
54
*
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
+∞
53.0
50
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
561.5
52.4
51
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
11.0
50.0
100
110
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
33.1
45.1
59
20
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
14.9
39.4
67
51
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.2
37.9
89
127
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
36.9
35
*
R51.80
ICD-10 Finland
Headache
4.5
34.4
140
394
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.1
34.1
158
503
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
33.4
255
1200
2132
FHL
Ventricular operators sunt
+∞
30.5
29
*
N03AX14
ATC
levetiracetam; systemic
11.7
28.8
54
51
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
38.5
28.7
36
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
28.4
136
437
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
30.5
28.0
37
13
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
27.3
26
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
12.8
27.3
49
42
ZXC86
NOMESCO Finland
Use of endoscopic device
31.1
26.6
35
12
XA800
NOMESCO Finland
Neuropsychological investigation
6.8
26.2
69
115
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
25.6
195
875
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
12.6
23.9
43
37
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.8
23.3
83
199
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
+∞
23.1
22
*
2133
FHL
Suntin revisio
+∞
23.1
22
*
H47.2
ICD-10 Finland
Optic atrophy
65.5
22.0
25
*
Q03.0
ICD-10 Finland
Malformations of aqueduct of Sylvius
+∞
22.0
21
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
21.4
127
472
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.7
20.9
49
69
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
19.3
20.7
31
17
N03AG01
ATC
valproic acid; systemic, rectal
5.3
20.6
66
140
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
19.9
19
*
N03AF02
ATC
oxcarbazepine; oral
8.3
19.7
44
57
R42
ICD-10 Finland
Dizziness and giddiness
2.8
19.2
148
647
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
19.7
18.8
28
15
L28
ICPC
Limited function/disability (L)
3.2
18.8
115
430
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
18.5
142
618
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
18.4
18.4
28
16
2130
FHL
Ventricular atrial shunt
+∞
17.8
17
*
XCK00
NOMESCO Finland
Perimetry
4.5
17.4
64
157
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.0
17.4
57
124
N03AB02
ATC
phenytoin; systemic
20.1
17.0
25
13
TAB00
NOMESCO Finland
Lumbar puncture
5.5
16.6
50
99
Z2445
NOMESCO Finland
Psychologist
4.9
16.5
55
122
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
16.2
67
184
ZXE20
NOMESCO Finland
More than three and less than five hours
2.9
16.2
110
441
H02AB02
ATC
dexamethasone; systemic
3.6
15.9
77
242
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
27.3
15.7
21
8
N28
ICPC
Limited function/disability (N)
14.3
15.7
26
19
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.5
15.6
30
30
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
10.2
15.4
30
31
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
24.2
15.2
21
9
ZXD35
NOMESCO Finland
Usual procedure
6.1
15.0
41
72
N18
ICPC
Paralysis/weakness
9.6
14.9
30
33
SPAT1229
SPAT
Assessment of need for aid
3.8
14.8
64
183
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
9.3
14.7
30
34
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
14.6
14
*
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
82.5
14.6
16
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
14.1
64
191
N03AF01
ATC
carbamazepine; oral, rectal
4.8
14.0
47
105
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
9.5
13.9
28
31
D33.30
ICD-10 Finland
Acoustic neuroma
24.6
13.9
19
8
G91
ICD-10 Finland
Hydrocephalus
+∞
13.6
13
*
K90
ICPC
Stroke/cerebrovascular accident
6.5
13.6
35
57
183
Kela drug reimbursment
Lamotrigin and topiramate
13.3
13.5
23
18
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
143.5
13.5
14
*
ZXA00
NOMESCO Finland
Right side
2.2
13.3
161
870
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
41.2
13.2
16
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
13.0
111
503
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
5.6
12.8
37
70
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.0
12.8
35
62
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.0
12.7
51
137
AAA10
NOMESCO Finland
Biopsy through craniotomy
71.6
12.6
14
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
71.6
12.6
14
*
H53.2
ICD-10 Finland
Diplopia
6.1
12.6
34
59
G81.1
ICD-10 Finland
Spastic hemiplegia
133.0
12.5
13
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
12.0
12.4
22
19
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
9.3
12.4
25
28
H02AB09
ATC
hydrocortisone; systemic
7.7
12.4
28
38
G93.0
ICD-10 Finland
Cerebral cysts
38.5
12.3
15
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
13.8
12.0
20
15
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
19.5
11.7
17
9
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
66.5
11.6
13
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
11.5
65
228
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.1
11.5
25
32
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
122.6
11.5
12
*
N05BA09
ATC
clobazam; oral
12.2
11.4
20
17
N29
ICPC
Neurological sympt/complt other
8.6
11.4
24
29
101
Kela drug reimbursment
Anterior pituitary hypofunction
15.5
11.4
18
12
H47.1
ICD-10 Finland
Papilloedema, unspecified
25.7
11.2
15
6
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
14.3
11.0
18
13
SPAT1216
SPAT
Assessment of functional ability
2.5
11.0
95
433
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
10.9
70
266
GBB00
NOMESCO Finland
Tracheostomy
12.3
10.9
19
16
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
28.7
10.8
14
5
R11
ICD-10 Finland
Nausea and vomiting
3.1
10.6
59
204
N99
ICPC
Neurological disease other
10.3
10.6
20
20
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.0
10.5
61
219
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
+∞
10.4
10
*
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
+∞
10.4
10
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
13.5
10.2
17
13
H53.4
ICD-10 Finland
Visual field defects
6.7
10.1
25
39
A28
ICPC
Limited function/disability NOS
2.4
10.1
96
456
E23.00
ICD-10 Finland
Panhypopituitarism
40.9
10.0
12
*
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
40.9
10.0
12
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
40.9
10.0
12
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
56.0
9.7
11
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
56.0
9.7
11
*
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
56.0
9.7
11
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
9.7
201
1316
WX730
NOMESCO Finland
Conventional respirator
7.4
9.6
22
31
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.5
9.6
33
77
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.3
9.5
48
156
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.9
9.5
58
213
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
101.8
9.4
10
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
30.6
9.4
12
*
2139
FHL
Other measure in this category
+∞
9.4
9
*
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
9.4
9
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
22.2
9.4
13
6
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
22.2
9.4
13
6
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
9.2
64
257
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
11.7
9.1
16
14
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
11.7
9.1
16
14
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
15.9
9.1
14
9
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
37.4
9.0
11
*
G04BD07
ATC
tolterodine; oral
3.7
9.0
38
108
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
7.4
8.8
20
28
R4110
NOMESCO Finland
Physiotherapy
1.9
8.7
142
846
R1250
NOMESCO Finland
Evaluation of functional capability
6.8
8.7
21
32
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
7.8
8.7
19
25
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
7.8
8.7
19
25
130
Kela drug reimbursment
Malignant tumour
2.9
8.6
51
186
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.5
8.5
19
26
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
28.0
8.5
11
*
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
91.4
8.4
9
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
8.4
69
304
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.1
8.4
18
23
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
+∞
8.4
8
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
8.4
8
*
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
8.4
8
*
C71.70
ICD-10 Finland
Malignant tumor of the brainstem without histology
+∞
8.4
8
*
P20
ICPC
Memory disturbance
2.4
8.3
73
331
Z3226
NOMESCO Finland
Physiotherapist
2.1
8.3
107
581
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.3
8.3
19
27
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
14.8
8.2
13
9
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
8.3
8.1
17
21
R41.0
ICD-10 Finland
Disorientation, unspecified
4.5
8.1
27
62
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
8.0
60
249
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.8
8.0
33
92
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
8.0
71
326
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.6
7.9
22
41
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.6
7.9
16
19
ZXC95
NOMESCO Finland
Use of surgical navigator
9.6
7.8
15
16
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.7
115
660
F83
ICD-10 Finland
Mixed specific developmental disorders
7.6
7.7
17
23
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
8.2
7.6
16
20
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.2
7.6
16
20
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
18.7
7.6
11
6
L01AX03
ATC
temozolomide; systemic
25.4
7.6
10
*
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
25.4
7.6
10
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
10.2
7.6
14
14
H01AC01
ATC
somatropin; parenteral
10.2
7.6
14
14
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
7.5
81
406
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
13.6
7.4
12
9
R4150
NOMESCO Finland
Neuropsychological rehabilitation
13.6
7.4
12
9
A06AD11
ATC
lactulose; oral
2.2
7.4
81
410
R4120
NOMESCO Finland
Occupational therapy
2.9
7.4
44
162
ZXE00
NOMESCO Finland
One hour or less
1.7
7.3
195
1351
G40.10
ICD-10 Finland
Simple partial seizures
11.1
7.3
13
12
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
11.1
7.3
13
12
N03AX18
ATC
lacosamide; systemic
11.1
7.3
13
12
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
7.3
7
*
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
+∞
7.3
7
*
34793
ICD-8 Finland
Other disease of brain, Hydrocephalus acquisitus NUD
+∞
7.3
7
*
AAA50
NOMESCO Finland
Intracranial endoscopy
+∞
7.3
7
*
D33.12
ICD-10 Finland
Cerebellum
+∞
7.3
7
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
7.3
7
*
AAW99
NOMESCO Finland
Other intracranial operation
+∞
7.3
7
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
7.3
7
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
+∞
7.3
7
*
74209
ICD-8 Finland
Congenital hydrocephalus, Unspecified
+∞
7.3
7
*
R27.0
ICD-10 Finland
Ataxia, unspecified
16.0
7.3
11
7
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.5
7.2
24
55
WX882
NOMESCO Finland
High dependency care
3.5
7.2
32
96
TJD20
NOMESCO Finland
Change of gastrostomy tube
20.3
7.2
10
5
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
6.2
7.1
18
30
H50.31
ICD-10 Finland
Intermittent exotropia
12.2
7.1
12
10
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
6.9
91
497
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.2
6.9
20
40
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
17.0
6.8
10
6
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
22.8
6.7
9
*
K91
ICPC
Cerebrovascular disease
6.6
6.7
16
25
SPAT1252
SPAT
Overall medication plan or its review
2.8
6.6
40
150
RT150
NOMESCO Finland
NA
10.2
6.6
12
12
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.2
6.5
32
104
WX872
NOMESCO Finland
Intensive care
3.1
6.5
34
116
2161
FHL
Neck ligation, big brain
70.7
6.4
7
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
70.7
6.4
7
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
6.4
64
312
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
6.4
63
304
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
5.6
6.3
17
31
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
5.6
6.3
17
31
Z3231
NOMESCO Finland
Registered nurse
1.7
6.3
145
955
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.5
6.3
47
197
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
6.3
6
*
Q04.6
ICD-10 Finland
Congenital cerebral cysts
+∞
6.3
6
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
6.3
6
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
+∞
6.3
6
*
74200
ICD-8 Finland
Congenital hydrocephalus, Communicans
+∞
6.3
6
*
AAF45
NOMESCO Finland
Fenestration of intracranial cyst
+∞
6.3
6
*
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
+∞
6.3
6
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
7.2
6.3
14
20
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
27.0
6.2
8
*
N03AX09
ATC
lamotrigine; oral
3.4
6.2
28
86
H53.0
ICD-10 Finland
Amblyopia ex anopsia
7.8
6.2
13
17
XX4AW
NOMESCO Finland
NA
7.8
6.2
13
17
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
6.1
29
92
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
12.7
6.1
10
8
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
12.7
6.1
10
8
R1260
NOMESCO Finland
Evaluation of communicative skills
5.0
6.1
18
37
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
127
34
48.09
211.32
2.6
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
135
82
21.41
166.89
2.5
1.9
e6/l
31.3
7.0
1.17
111
62
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
135
82
21.41
166.89
2.5
2.0
e6/l
1075.8
242.1
1.83
115
64
(3044290) Cell count panel - Cerebral spinal fluid
122
76
20.27
148.41
2.7
2.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
90
32
33.35
136.59
2.7
2.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
79
19
48.29
133.44
2.8
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
75
45
19.10
91.72
2.8
2.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
37
21
18.80
45.85
1.6
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
120
447
3.15
24.70
10.8
8.9
mmol/l
1.6
1.2
0.48
92
359
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
228
1243
2.41
21.76
2.8
2.1
u/l
312.4
260.5
0.17
215
1172
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
21
11.38
21.68
1.6
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
229
1329
2.23
18.11
2.9
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
187
1019
2.26
17.06
2.5
2.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
191
1060
2.22
16.59
4.6
4.2
%
89.8
89.3
0.13
185
1035
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
26
7.94
14.51
1.5
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
288
1947
1.99
14.15
10.1
6.6
mmol/l
1.2
1.2
5.29
263
1761
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
24
8.16
14.10
1.6
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
284
1960
1.92
12.65
4.4
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
253
1694
1.90
12.24
5.6
8.6
inr
1.2
1.2
0.23
68
498
(3023368) Bacteria identified in Blood by Culture
189
1162
1.95
11.72
4.9
4.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
339
2525
1.88
11.47
8.7
5.0
mmol/l
6.7
6.6
0.21
332
2348
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
15
6
25.62
11.19
1.2
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
298
2145
1.84
11.11
9.5
7.1
mmol/l
1.2
1.2
2.86
263
1815
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
40
5.15
9.63
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
94
484
2.13
9.32
10.0
6.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
59
4.21
9.07
1.5
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
60
259
2.48
8.98
10.6
5.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
116
666
1.94
8.48
4.1
4.5
mmol/l
0.8
0.8
0.87
105
622
(3036481) Cortisol [Moles/volume] in Serum or Plasma
82
418
2.13
8.31
3.8
2.1
nmol/l
336.9
370.7
0.97
76
388
(3003181) Sodium [Moles/volume] in Urine
26
75
3.59
7.91
2.0
1.8
mmol/l
99.1
69.4
1.72
26
70
(3007853) Bacteria identified in Skin by Aerobe culture
93
506
2.01
7.90
2.3
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
204
2.48
7.43
10.3
12.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
67
332
2.16
7.28
3.7
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
87
1460
0.52
7.26
2.5
2.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
76
401
2.04
7.01
11.5
9.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
182
1261
1.66
6.86
5.2
3.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
101
592
1.86
6.85
5.4
6.7
mmol/l
1.0
1.1
1.69
91
547
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
214
1546
1.62
6.83
4.3
3.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
68
349
2.08
6.75
2.3
2.4
ug/l
7.8
7.1
0.07
53
308
(3020393) Adenovirus Ag [Presence] in Stool
10
14
7.26
6.72
1.6
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
113
703
1.76
6.27
2.3
1.9
—
—
—
0
0
(3020891) Body temperature
39
163
2.50
6.27
12.0
4.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
83
3.11
6.15
1.6
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
48
3.84
6.13
1.0
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
238
1801
1.56
6.06
5.4
5.1
g/l
34.5
35.9
3.42
222
1689
(3009214) Lutropin [Units/volume] in Serum or Plasma
32
125
2.66
5.90
3.4
1.7
u/l
4.6
7.6
2.28
26
96
(3019309) Folate [Moles/volume] in Red Blood Cells
121
784
1.69
5.77
1.9
1.8
nmol/l
1235.8
1170.7
0.34
96
591
(3042936) Bacteria identified in Isolate by Culture
101
628
1.74
5.58
2.4
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
83
490
1.82
5.46
2.2
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
134
913
1.62
5.22
3.3
2.6
e6/l
5.1
5.8
0.30
124
804
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
82
492
1.78
5.11
2.2
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
190
1414
1.52
5.00
3.6
3.3
mmol/l
2.3
2.4
0.59
158
1244
(3031040) Bacteria [#/volume] in Urine by Automated count
337
2819
1.49
4.98
6.8
4.5
e6/l
3031.3
2720.3
—
9
53
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
41
3.73
4.95
2.9
3.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
139
970
1.58
4.86
4.9
3.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
36
164
2.28
4.83
2.3
1.8
ug/l
0.2
3.2
1.11
28
147
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
25
4.47
4.58
1.2
1.0
u/l
1.5
1.1
—
6
17
(3018405) Lactate [Moles/volume] in Arterial blood
34
155
2.27
4.56
11.0
3.3
mmol/l
1.5
1.4
0.14
34
149
(4035726)
62
354
1.85
4.54
1.4
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
162
1197
1.50
4.31
4.1
3.2
e6/l
0.4
0.5
0.26
132
896
(3021387) Prolactin [Units/volume] in Serum or Plasma
29
129
2.32
4.13
2.4
1.5
mu/l
323.8
288.6
0.27
29
120
(21494755) Public health laboratory ask at order entry panel
14
386
0.35
4.08
1.4
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
123
871
1.53
3.97
3.8
2.8
mosm/kgh2o
539.3
556.0
0.33
110
741
(3036489) Thrombin time
34
165
2.13
3.95
2.5
3.5
s
21.0
22.0
0.77
29
153
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
106
728
1.56
3.92
3.2
2.9
e6/l
1.6
0.9
1.46
68
417
(44806118)
18
65
2.83
3.89
1.2
1.7
—
—
—
0
0
(44790048)
18
65
2.83
3.89
1.2
1.7
—
—
—
0
0
(44790049)
18
65
2.83
3.89
1.2
1.7
—
—
—
0
0
(44790047)
18
65
2.83
3.89
1.2
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
133
2.25
3.87
1.4
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
121
2.29
3.80
2.7
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
155
1162
1.46
3.77
4.1
3.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
173
1339
1.42
3.52
4.6
3.3
e6/l
21.9
115.0
1.20
148
1027
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
108
765
1.51
3.46
3.2
2.9
mmol/l
2.5
2.5
0.07
92
674
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
202
1611
1.40
3.45
3.8
3.7
ng/l
32.9
39.7
0.40
153
1113
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
18
5.06
3.38
1.1
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
71
461
1.62
3.32
6.2
5.1
mmol/l
1.7
1.7
0.02
61
362
(3018418) pH of Serum or Plasma
163
1262
1.41
3.28
3.7
4.0
ph
7.4
7.4
0.06
29
230
(3019150) Specific gravity of Urine by Refractometry
129
960
1.45
3.22
6.0
3.8
kg/l
1.0
1.0
0.74
17
133
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
131
2.12
3.18
2.8
3.5
u/ml
0.3
0.4
0.16
13
69
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
316
1.71
3.13
1.8
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
8
7.57
3.06
1.0
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
264
2235
1.34
2.99
7.0
6.5
umol/l
12.0
11.7
0.09
247
2109
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
30
3.38
2.92
1.6
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
373
4088
0.73
2.86
4.0
4.3
mmol/l
1.4
1.5
2.20
341
3761
(3009542) Hematocrit [Volume Fraction] of Blood
368
4038
0.74
2.81
23.4
15.2
%
39.1
39.8
0.94
249
2996
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
677
0.60
2.61
1.3
1.3
u/ml
26.3
10.0
0.51
17
257
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
367
0.47
2.60
1.6
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
181
0.32
2.58
2.0
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
387
4198
0.74
2.57
4.5
4.8
mmol/l
2.7
2.7
0.79
347
3857
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
7
7.20
2.55
1.2
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
7
7.20
2.55
1.2
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
11
5.50
2.55
1.0
1.0
miu/ml
1732.0
1405.3
—
6
11
(40757373) Influenza virus identified in Isolate
6
11
5.50
2.55
1.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
189
1553
1.33
2.52
5.4
3.8
e6/l
91.4
77.9
0.18
153
1096
(4027681)
9
26
3.50
2.49
1.6
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
823
1.40
2.49
3.6
3.8
ng/l
1091.4
339.4
0.43
80
642
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
116
886
1.39
2.47
1.6
1.7
pmol/l
414.2
6748073.8
0.50
93
741
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
94
698
1.42
2.36
3.8
3.1
e6/l
4.7
1.9
1.09
58
389
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
126
1.95
2.34
1.8
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
355
3879
0.77
2.33
5.8
5.7
mmol/mol
39.7
39.7
0.01
326
3613
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
251
2864
0.78
2.31
3.2
3.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
9
5.59
2.22
2.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
364
3955
0.77
2.21
3.6
3.9
mmol/l
1.3
1.3
0.29
333
3635
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
695
0.65
2.18
1.3
1.3
iu/ml
16.8
34.9
2.64
15
212
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
61
2.33
2.16
1.9
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
74
535
1.44
2.15
31.5
23.4
inr
1.3
1.3
—
9
81
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
11
43
2.59
2.10
2.7
2.6
e9/l
0.1
0.2
0.80
11
34
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
382
4115
0.77
2.09
4.0
4.4
mmol/l
4.5
4.6
1.52
344
3813
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
10
5.03
2.07
1.2
7.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
10
5.03
2.07
1.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
20
3.53
2.06
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
20
3.53
2.06
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
20
3.53
2.06
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
44
2.53
2.02
2.6
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
126
1.86
2.01
1.8
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
140
1137
1.31
1.98
6.1
3.8
estimate
0.0
0.0
0.00
36
375
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
204
1740
1.27
1.98
2.5
2.4
nmol/l
72.5
76.2
1.03
182
1555
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
254
0.46
1.96
1.1
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
12
51
2.38
1.96
1.9
2.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
11
45
2.47
1.94
2.6
2.5
e6/l
413.5
485.2
0.30
11
34
(40758558) Short blood count panel - Blood
138
1124
1.30
1.91
10.2
7.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
22
3.21
1.88
1.7
2.0
u/ml
467.9
964.6
—
7
22
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
177
1.67
1.80
2.1
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
29
2.78
1.79
1.3
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
47
323
1.50
1.79
3.0
2.8
ml/min/173m2
69.8
65.5
0.21
16
135
(3027945) Reticulocytes/100 erythrocytes in Blood
69
512
1.40
1.76
2.4
3.2
%
1.9
1.7
0.41
59
465
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
18
3.36
1.75
1.0
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
39
259
1.54
1.73
1.7
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
380
4064
0.80
1.71
4.3
4.4
mmol/l
6.0
5.9
0.29
347
3698
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
164
1.68
1.71
2.1
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
39
566
0.67
1.68
2.5
2.6
ug/g
455.9
132.4
0.81
30
449
(3051593) INR in Capillary blood by Coagulation assay
6
19
3.18
1.66
3.3
15.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
49
2.27
1.64
5.3
2.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
14
3.59
1.62
3.0
3.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
14
3.59
1.62
6.0
6.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
471
4897
0.75
1.58
31.4
20.5
g/l
131.5
135.5
6.66
466
4819
(3014271) Vancomycin [Susceptibility]
7
26
2.71
1.58
4.4
2.3
—
—
—
0
0
(4062490)
11
50
2.22
1.58
1.4
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
471
4895
0.76
1.55
31.2
20.4
e9/l
7.3
6.7
5.50
463
4745
(3026361) Erythrocytes [#/volume] in Blood
471
4894
0.76
1.54
31.2
20.3
e12/l
4.4
4.5
2.73
463
4745
(3035941) MCH [Entitic mass]
471
4893
0.76
1.52
31.1
20.2
pg
29.9
30.2
2.66
465
4819
(3024731) MCV [Entitic volume]
471
4893
0.76
1.52
31.1
20.3
fl
89.8
90.6
2.82
465
4820
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
243
1.51
1.51
1.9
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
471
4891
0.76
1.50
31.2
20.3
e9/l
267.2
249.3
5.00
464
4757
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
10
45
2.24
1.47
3.1
1.4
u/l
7.2
26.0
—
10
35
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
80
1.90
1.46
1.9
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
67
862
0.75
1.45
1.7
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
16
3.14
1.44
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
16
3.14
1.44
1.4
1.1
nmol/l
139.2
132.6
—
5
16
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
16
3.14
1.44
1.2
1.1
%
103.8
88.9
—
5
16
(42870588) Differential panel, method unspecified - Blood
173
1496
1.23
1.42
6.7
6.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
139
0.43
1.41
1.8
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
22
134
1.67
1.41
3.1
4.5
g/l
3.2
3.4
0.24
22
129
(3028626) Oxygen [Partial pressure] in Capillary blood
30
198
1.54
1.40
13.6
4.6
kpa
9.6
9.0
1.03
30
180
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
261
0.56
1.40
1.3
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
26
166
1.59
1.40
1.3
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
34
487
0.68
1.39
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
67
1.96
1.39
1.3
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
322
2964
1.20
1.37
5.7
4.3
—
—
—
0
0
(3000492) Spirometry study
27
403
0.65
1.36
1.1
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
59
763
0.75
1.33
2.9
2.9
ug/l
0.7
0.8
1.03
41
481
(3019198) Lymphocytes [#/volume] in Blood
253
2283
1.20
1.32
7.8
6.0
e9/l
2.0
2.0
0.04
219
2026
(3008898) HLA-B27 [Presence]
9
173
0.51
1.31
1.2
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
190
1672
1.21
1.30
2.3
2.0
pmol/l
87.6
94.8
1.40
96
865
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
372
3946
0.83
1.29
17.6
12.9
ml/min/173m2
86.9
81.7
3.55
314
3209
(3021960) Folate [Moles/volume] in Serum or Plasma
121
1017
1.24
1.29
1.5
1.5
nmol/l
20.8
20.7
0.01
107
855
(3013650) Neutrophils [#/volume] in Blood by Automated count
282
2575
1.19
1.28
11.6
9.3
e9/l
4.6
4.0
2.15
252
2253
(3035350) Ketones [Presence] in Urine by Test strip
232
2084
1.19
1.26
5.3
3.6
estimate
0.0
0.0
0.00
40
388
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
85
1.79
1.24
1.7
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
26
2.32
1.19
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
38
2.12
1.19
6.0
2.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
33
0.00
1.16
0.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
95
1.70
1.15
2.2
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
350
3715
0.84
1.14
25.9
17.2
%
13.9
13.7
1.43
345
3646
(3022145) Colonoscopy Study observation
34
466
0.71
1.12
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
207
0.57
1.12
1.2
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
51
1.98
1.12
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
31
218
1.45
1.11
4.0
3.5
mmol/l
25.0
25.0
0.03
31
213
(3037121) Protein [Mass/volume] in Urine
25
169
1.50
1.09
2.9
4.1
g/l
0.3
0.3
0.09
14
77
(3001604) Monocytes [#/volume] in Blood
244
2229
1.17
1.04
7.8
5.9
e9/l
0.6
0.6
0.92
210
1929
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
60
1.85
1.03
1.0
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
336
1.34
1.00
10.7
4.6
mmol/l
1.3
2.0
0.94
33
238
(3022313) Gas panel - Capillary blood
37
275
1.37
1.00
10.6
4.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
108
1252
0.83
0.98
4.1
4.0
mg/mmol
10.3
9.4
0.08
69
803
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
108
1.59
0.97
1.5
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
173
0.57
0.96
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
430
0.73
0.96
1.3
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
161
1431
1.18
0.96
3.2
3.5
u/l
36.0
32.2
0.20
152
1368
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
351
3312
1.16
0.95
4.1
3.7
pmol/l
15.2
14.7
2.17
316
2988
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
37
1.90
0.94
1.1
1.1
nmol/l
1.5
1.5
—
7
32
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
27
2.24
0.93
1.2
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
94
1.61
0.91
1.4
2.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
81
679
1.23
0.91
2.5
2.4
umol/l
11.4
13.3
1.38
72
628
(3011288) Drugs identified in Urine by Screen method
7
127
0.55
0.89
1.6
2.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
251
2319
1.15
0.89
8.3
6.3
e9/l
0.2
0.2
1.56
217
2043
(40761536) Microorganisms panel - Urine sediment
26
356
0.72
0.88
8.8
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
231
2123
1.15
0.88
5.4
3.7
estimate
0.0
0.0
0.50
37
373
(3044927) Protein electrophoresis panel - Urine
8
43
1.87
0.87
1.3
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
243
2243
1.15
0.87
7.9
5.9
e9/l
0.0
0.0
0.28
210
1945
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
399
1.28
0.86
2.3
2.4
u/l
31.6
30.1
0.13
35
329
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
587
0.78
0.86
1.3
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
228
2097
1.15
0.86
6.8
5.0
estimate
0.0
0.0
0.00
38
383
(3030981) Hyaline casts [#/volume] in Urine by Automated count
33
248
1.35
0.86
4.1
2.6
e6/l
0.5
0.2
0.89
33
240
(4010399)
22
308
0.70
0.85
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
88
1.61
0.85
4.4
3.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
88
1.61
0.85
3.1
2.6
%
16.6
15.8
—
6
45
(3037522) Nuclear Ab [Titer] in Serum
45
564
0.78
0.84
1.3
1.4
titre
1146.7
441.3
—
9
120
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
138
0.57
0.84
1.1
1.1
—
12.4
—
0
18
(3020961) Endomysium IgA Ab [Titer] in Serum
17
247
0.68
0.81
1.1
1.1
titre
—
13.5
—
0
6
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
47
1.71
0.81
1.0
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
70
586
1.22
0.81
2.7
2.5
%
20.9
22.8
0.46
61
508
(3022096) Basophils/100 leukocytes in Blood
224
2065
1.14
0.80
7.9
6.1
%
0.6
0.7
1.27
209
1933
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
151
0.59
0.79
1.2
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
24
0.00
0.79
0.0
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
103
1175
0.85
0.78
5.0
3.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
10.3
—
0.7
—
0
27
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
98
1121
0.85
0.77
1.8
1.7
mmol/l
1.3
1.4
0.41
84
939
(3006504) Eosinophils/100 leukocytes in Blood
229
2122
1.13
0.75
7.8
6.0
%
2.4
2.9
2.97
214
1979
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
179
1636
1.14
0.72
6.0
3.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
109
1.48
0.71
1.3
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
26
1.93
0.71
1.0
4.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
9
143
0.62
0.70
1.6
1.7
—
304.0
—
0
5
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
411
1.24
0.70
3.3
3.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
12
77
1.57
0.69
2.5
3.2
nmol/l
0.9
0.9
—
6
60
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
120
0.58
0.68
1.7
4.1
—
2.5
—
0
12
(3026493) Urate [Moles/volume] in Serum or Plasma
93
1056
0.86
0.67
2.3
2.9
umol/l
331.4
8165.6
5.01
84
902
(40768797) Stomach Pathology biopsy report
48
578
0.81
0.66
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
137
1.40
0.65
5.8
3.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
73
629
1.18
0.65
2.5
2.4
g/l
2.2
2.3
0.64
65
583
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
122
1095
1.15
0.65
3.0
2.3
mg/l
3.4
3.0
0.64
105
941
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
266
2815
0.89
0.64
3.0
3.3
u/l
51.7
46.7
0.50
247
2633
(3002030) Lymphocytes/100 leukocytes in Blood
233
2180
1.12
0.63
7.9
6.2
%
26.5
28.6
1.74
217
2046
(3019069) Monocytes/100 leukocytes in Blood
228
2131
1.12
0.63
8.0
6.3
%
8.6
8.7
0.14
213
2004
(3009508) Creatinine [Moles/volume] in Urine
121
1341
0.88
0.63
3.3
3.2
mmol/l
7.2
7.6
0.35
102
1123
(3012516) Albumin [Mass/volume] in Urine
107
1193
0.87
0.61
3.1
3.2
mg/l
755.2
275.6
0.31
71
776
(21491868) Cryoglobulin [Mass/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
166
1.34
0.59
2.5
2.7
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
23
0.00
0.58
0.0
1.7
—
7.4
—
0
16
(3004451) EKG impression Narrative
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
98
1.44
0.57
1.2
1.2
—
—
—
0
0
(4146454)
6
36
1.67
0.57
3.3
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
86
0.58
0.56
1.6
5.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
183
0.70
0.56
1.2
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
183
0.70
0.56
1.2
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
121
1330
0.88
0.56
4.5
4.7
ug/l
1.6
2.5
1.87
111
1186
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
37
1.63
0.55
2.3
2.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
171
0.70
0.55
1.2
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
125
0.63
0.55
1.1
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
146
1341
1.12
0.55
2.6
2.5
u/l
50.4
55.5
1.47
134
1242
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
60
1.51
0.54
1.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
1.3
1.3
nmol/l
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
61
1.48
0.54
1.4
4.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
27
214
1.28
0.53
3.7
3.2
%
0.7
0.7
0.12
27
209
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
136
0.66
0.52
1.7
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
309
2958
1.10
0.51
3.4
3.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
168
0.71
0.51
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
13
92
1.42
0.51
7.0
3.5
mmol/l
2.0
2.6
—
8
58
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
507
0.84
0.51
4.8
4.2
%
30.2
31.5
0.41
29
335
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
485
0.83
0.50
1.6
2.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
13
178
0.72
0.49
1.0
1.5
—
9.4
—
0
6
(4094501)
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
155
0.70
0.49
2.7
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
450
0.83
0.47
1.5
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
151
1623
0.90
0.47
2.2
2.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
451
4605
0.89
0.47
11.8
10.2
u/l
27.7
26.2
0.84
436
4441
(3026389) Candida sp identified in Specimen by Organism specific culture
7
48
1.46
0.47
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
34
283
1.21
0.46
1.9
2.7
e9/l
4.4
3.9
0.52
24
229
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
1.4
1.3
nmol/l
0.5
0.5
—
7
43
(1761482) Bacteria [#/volume] in Urine by Culture
8
121
0.66
0.46
4.9
4.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
41
349
1.19
0.45
1.4
3.1
g/l
69.6
66.5
1.75
34
313
(3003434) Protein [Mass/volume] in Pleural fluid
7
51
1.38
0.44
1.7
1.5
g/l
41.5
33.5
—
7
45
(3027944) Amphetamines [Presence] in Urine
14
184
0.75
0.42
1.1
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
293
0.81
0.41
1.1
1.2
iu/ml
273.1
153.9
—
6
114
(4024509)
5
33
1.52
0.41
1.4
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
126
1168
1.10
0.41
1.5
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
8.8
—
0
17
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
53
466
1.15
0.40
3.6
4.6
u/l
216.2
268.2
1.49
46
435
(3037556) Urate [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
102
0.68
0.40
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
105
0.66
0.39
1.3
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
34
289
1.19
0.39
4.0
2.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
181
0.77
0.38
1.1
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
69
1.31
0.37
1.8
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
135
0.74
0.36
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
1.9
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
90
1.34
0.36
1.5
4.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
156
0.76
0.35
1.8
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
340
3303
1.08
0.35
8.1
7.4
u/l
88.4
81.5
1.31
320
3079
(3002179) Metamyelocytes/100 leukocytes in Blood
28
329
0.84
0.34
5.1
4.1
%
0.7
0.4
0.74
11
85
(3019832) Treponema pallidum Ab [Presence] in Serum
31
360
0.85
0.34
1.1
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
1.5
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
59
532
1.12
0.33
2.5
3.7
umol/l
22.1
9.3
0.94
47
462
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
252
0.83
0.32
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.3
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
251
0.83
0.31
1.3
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
42
372
1.14
0.31
2.7
3.0
e9/l
72.8
69.9
0.22
33
285
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
141
0.78
0.29
1.2
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
56
508
1.11
0.29
1.4
1.5
—
—
—
0
0
(4306422)
7
57
1.23
0.29
1.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
97
1037
0.92
0.28
1.3
1.3
u/ml
1.2
1.8
0.29
22
257
(3021901) Oxygen saturation in Capillary blood
12
94
1.28
0.28
3.3
2.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
100
1067
0.92
0.28
3.8
4.2
%
23.2
21.9
0.34
44
502
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
447
4401
1.08
0.28
22.4
13.9
mg/l
26.1
24.0
0.68
373
3446
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
140
1.22
0.27
2.0
2.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
9
118
0.76
0.27
1.0
2.2
g/l
0.0
0.0
—
9
106
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
64
1.25
0.27
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
22
257
0.85
0.27
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
246
0.85
0.26
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
86
1.28
0.26
5.6
3.5
%
53.9
55.9
0.13
11
86
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
72
0.69
0.26
1.0
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
321
1.13
0.25
1.1
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
75
1.20
0.25
3.3
4.0
%
59.4
63.2
—
9
75
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
223
0.85
0.25
3.1
2.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
96
1.26
0.24
2.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
96
1.26
0.24
2.1
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
83
0.72
0.24
1.0
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
84
0.71
0.24
1.8
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
222
2148
1.06
0.24
7.8
6.0
%
58.1
56.3
1.15
208
2025
(3025159) Blasts/100 leukocytes in Blood
29
327
0.88
0.23
5.0
4.3
%
0.0
1.0
0.57
13
94
(4034850)
16
134
1.20
0.23
14.1
9.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
91
0.77
0.22
1.6
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
93
0.75
0.22
1.9
1.2
—
—
—
0
0
(4281824)
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
101
0.79
0.21
1.8
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
27.5
—
0
12
(3014891) Appearance of Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4015189)
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
13
0.00
0.21
0.0
4.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
92
971
0.94
0.20
6.6
4.8
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
0.7
—
0
6
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3013512) EKG study
116
1214
0.94
0.20
3.3
3.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
51
1.18
0.19
1.5
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
127
1218
1.06
0.19
2.8
3.3
ng/l
1070.9
1478.1
1.07
108
1043
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
48
517
0.92
0.18
1.4
1.8
%
1.5
1.5
0.11
40
462
(3045424) Erythrocytes [Presence] in Urine
7
58
1.21
0.18
1.0
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
402
3966
1.05
0.18
4.7
4.5
mu/l
1.9
2.2
0.53
372
3612
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
101
964
1.06
0.18
2.1
1.9
mg/l
1.2
1.3
0.18
78
743
(3021440) Promyelocytes/100 leukocytes in Blood
31
341
0.90
0.18
4.8
4.3
%
0.1
0.1
0.45
15
107
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.4
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
67
0.74
0.17
1.0
2.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
69
0.72
0.17
1.2
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
70
0.71
0.17
1.4
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
83
1.21
0.15
3.5
3.2
e9/l
4.3
4.2
—
10
83
(3017181) Myelocytes/100 leukocytes in Blood
34
364
0.93
0.12
4.6
4.2
%
0.9
0.8
0.07
16
119
(3003338) MCHC [Mass/volume]
381
3775
1.03
0.10
29.3
18.0
g/l
332.4
332.8
0.37
376
3749
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
45
1.11
0.10
2.6
4.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
46
1.09
0.09
3.8
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
47
1.06
0.09
1.6
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
47
1.06
0.09
1.6
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
107
1.12
0.08
1.5
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
60
0.83
0.08
2.4
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
164
0.91
0.08
1.4
2.0
g/l
6.8
7.4
—
10
119
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
164
0.91
0.08
1.4
2.0
g/l
3.8
3.7
—
10
114
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
164
0.91
0.08
1.4
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
53
510
1.04
0.08
1.2
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
84
0.83
0.07
1.1
1.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
87
1.04
0.07
1.8
1.7
pmol/l
213.3
228.3
—
9
81
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
95
0.84
0.06
1.9
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
437
0.96
0.06
4.3
4.0
ug/l
6.7
32.1
0.80
37
370
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
142
0.91
0.06
3.5
2.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
100
0.90
0.06
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
102
0.88
0.06
1.3
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
93
950
0.97
0.06
1.6
1.6
g/l
1.9
2.3
1.26
48
563
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
60
616
0.97
0.05
1.4
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
218
1.06
0.05
2.8
3.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
37
358
1.04
0.04
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
101
1.09
0.04
1.5
1.7
iu/l
7.2
6.9
—
6
30
(3013707) Erythrocyte sedimentation rate by Westergren method
320
3217
0.99
0.03
3.8
4.1
mm/h
14.7
11.8
2.15
291
2953
(3004588) Protein electrophoresis panel - Serum or Plasma
29
282
1.03
0.02
1.3
2.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
77
763
1.01
0.01
1.5
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
145
0.96
0.00
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
145
0.96
0.00
1.3
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
134
0.97
0.00
1.2
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
97
1.03
0.00
1.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
143
0.98
0.00
1.3
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
49
494
0.99
0.00
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
39
387
1.01
0.00
3.6
4.3
—
—
—
0
0
(1002224) Polysomnography panel
18
178
1.01
0.00
1.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
101
0.99
0.00
1.3
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
455
4547
1.00
0.00
18.5
12.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
201
2007
1.00
0.00
11.6
9.5
e9/l
0.0
0.0
0.27
159
1625
(3001122) Ferritin [Mass/volume] in Serum or Plasma
186
1857
1.00
0.00
3.0
2.7
ug/l
122.1
120.7
0.04
169
1713
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
80
1.00
0.00
1.3
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
76
0.92
0.00
12.3
3.4
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
53.5
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.4
—
0.6
—
0
5
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
4.3
—
0
6
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
59
1.02
0.00
1.2
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
68
0.88
0.00
1.0
1.3
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
169.6
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
58
0.86
0.00
1.4
2.9
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
58
0.86
0.00
1.2
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.9
—
0
7
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.2
—
0
6
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
9.4
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
58
0.86
0.00
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
59
0.85
0.00
1.2
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
59
0.85
0.00
1.2
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.0
—
9112.0
—
0
8
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
11.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HCOBSTR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCOBSTR | 4.198 [3.58, 4.93] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.317 |
During the follow-up period (1.1.1998 — 31.12.2019), 633 out of 1803 females with G6_HCOBSTR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCOBSTR | 4.142 [3.49, 4.92] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 664 out of 1881 males with G6_HCOBSTR died.
Mortality risk
Mortality risk for people of age
years, who have G6_HCOBSTR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.303% | 0.858% |
| 5 | 2.097% | 4.966% |
| 10 | 5.729% | 12.13% |
| 15 | 11.161% | 22.418% |
| 20 | 19.411% | 35.9% |
Relationships between endpoints
↥Index endpoint: G6_HCOBSTR – Obstructive hydrocephalus
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data